drugset / Trial / NCT01597531
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether addition of 1 or 2 medicines after gastric banding can improve remission of type 2 diabetes.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
| Comparator | Orlistat | Small molecule | 60 mg | Oral |